1. MP54-02 TWO-YEAR EFFICACY FOLLOW-UP OF A PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUÉRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN RECURRENT OR PERSISTENT HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN TREATMENT. (May 2022) Authors: Alanee, Shaheen; Montgomery, Jazzmyne; Sana, Sherjeel; El-Zawahry, Ahmed; Peabody, James; Pearce, Tiffany; Adams, Nicole; Deebajah, Mustafa; Dynda, Danuta; Babaian, Kara; Crabtree, Jane; Delfino, Kristin; McVary, Kevin; Robinson, Kathy; Rao, Krishna Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗